OrbiMed Israel GP Ltd.

Insider Reports History

Location
Herzliya
Signature
OrbiMed Israel BioFund GP Limited, /s/ Douglas Coon, Chief Compliance Officer
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by OrbiMed Israel GP Ltd.:

Company Role Class Num Shares Value Price $ Report Date Ownership
9 METERS BIOPHARMA, INC. 10%+ Owner Common Stock 8,565,974 $10,364,829 $1.21 25 Jun 2021 Indirect
Chemomab Therapeutics Ltd. 10%+ Owner American Depository Shares 2,241,274 $10,108,146 $4.51 03 Jan 2023 Indirect
9 METERS BIOPHARMA, INC. 10%+ Owner Stock Option (right to buy) 80,556 $103,917 $1.29 11 May 2021 Indirect

Insider Reports Filed by OrbiMed Israel GP Ltd.

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CMMB Chemomab Therapeutics Ltd. 03 Jan 2023 2 -$1,207,759 4 10%+ Owner 05 Jan 2023, 15:49
NMTR 9 METERS BIOPHARMA, INC. 23 Jun 2021 3 -$20,932,965 4 10%+ Owner 25 Jun 2021, 19:08
NMTR 9 METERS BIOPHARMA, INC. 11 May 2021 4 $20,836 4 10%+ Owner 13 May 2021, 18:34